| Company Name: |
LGM Pharma
|
| Tel: |
1-(800)-881-8210 |
| Email: |
inquiries@lgmpharma.com |
| Products Intro: |
Product Name:BreMazocine
CAS:75684-07-0
Purity:Typically NLT 98%
|
| Company Name: |
Nantong QuanYi Biotechnology Co., Ltd
|
| Tel: |
0513-66337626 18051384581 |
| Email: |
sales@chemhifuture.com |
| Products Intro: |
Product Name:Bremazocine
CAS:75684-07-0
Purity:98%+ HPLC Package:10mg，500mg，1g，2g，5g，10g，More
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:Bremazocine
CAS:75684-07-0
Package:25mg/RMB 43100
|
bremazocine manufacturers
- Bremazocine
-
- $5580.00 / 25mg
-
2025-08-21
- CAS:75684-07-0
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | bremazocine Basic information |
| Product Name: | bremazocine | | Synonyms: | [2R,(-)]-6-Ethyl-1,2,3,4,5,6-hexahydro-3-[(1-hydroxycyclopropyl)methyl]-11,11-dimethyl-2,6-methano-3-benzazocin-8-ol;2-(1-Hydroxy-cyclopropylmethyl)-5-ethyl-9,9-dimethyl-2'-hydroxy-6,7-benzomorphan;2,6-Methano-3-benzazocin-8-ol, 6-ethyl-1,2,3,4,5,6-hexahydro-3-((1-hydroxycyclopropyl)methyl)-11,11-dimethyl-, (2R)-;2,6-Methano-3-benzazocin-8-ol, 6-ethyl-1,2,3,4,5,6-hexahydro-3-[(1-hydroxycyclopropyl)methyl]-11,11-dimethyl-, (2R,6S)- | | CAS: | 75684-07-0 | | MF: | C20H29NO2 | | MW: | 315.45 | | EINECS: | | | Product Categories: | | | Mol File: | 75684-07-0.mol |  |
| | bremazocine Chemical Properties |
| Boiling point | 451.2±45.0 °C(Predicted) | | density | 1.155±0.06 g/cm3(Predicted) | | pka | 10.12±0.60(Predicted) |
| | bremazocine Usage And Synthesis |
| Description | Bremazocineis a potent, log-acting opiate kappa-agonist & centrally acting analgesic. | | Uses | Bremazocine is a potent opioid kappa receptor agonist with analgesic activity. Bremazocine induces peripheral analgesia by releasing endogenous norepinephrine. The analgesic effect of bremazocine is associated with interaction with adenosine receptors. Bremazocine produces a dose-dependent peripheral analgesia after topical application. The effect of bremazocine is affected by nonselective α(2) adrenaline receptor antagonists, suggesting that it acts through a norepinephrine pathway[1]. | | Definition | ChEBI: Bremazocine is a benzazocine. | | References | [1] Mu, delta, and kappa opioid receptor agonists induce peripheral antinociception by activation of endogenous noradrenergic system |
| | bremazocine Preparation Products And Raw materials |
|